1. Grabowski, H. G. Public policy and pharmaceutical innovation. Health Care Financ. Rev. 4, 75–87 (1982).
2. Fruits of Genomics (Lehman Brothers, New York, 2001).
3. Edmunds, R. et al. Splicing a cost squeeze into the genomics revolution. McKinsey Quarterly 2, 15–18 (2001).
4. Hopkins, A. & Groom, C. The druggable genome. Nature Rev. Drug Discov. 1, 727–730 (2002).
5. Ma, P. & Zemmel, R. Value of novelty? Nature Rev. Drug Discov. 1, 571–572 (2002).